Identification and characterization of alternative STK39 transcripts within human and mouse kidneys reveals species-specific regulation of blood pressure
PublisherAmerican Physiological Society
MetadataShow full item record
AbstractSTK39 encodes a serine threonine kinase, SPAK, which is part of a multi-kinase network that determines renal Na+ reabsorption and blood pressure (BP) through regulation of sodium-chloride co-transporters in the kidney. Variants within STK39 are associated with susceptibility to essential hypertension, and constitutively active SPAK mice are hypertensive and hyperkalemic, similar to familial hyperkalemic hyperkalemia in humans. SPAK null mice are hypotensive and mimic Gitelman syndrome, a rare monogenic salt wasting human disorder. Mice exhibit nephron segment-specific expression of full length SPAK and N-terminally truncated SPAK isoforms (SPAK2 and KS-SPAK) with impaired kinase function. SPAK2 and KS-SPAK function to inhibit phosphorylation of cation co-transporters by full length SPAK. However, the existence of orthologous SPAK2 or KS-SPAK within the human kidney, and the role of such SPAK isoforms in nephron segment-specific regulation of Na+ reabsorption, still have not been determined. In this study, we examined both human and mouse kidney transcriptomes to uncover novel transcriptional regulation of STK39. We established that humans also express STK39 transcript isoforms similar to those found in mice but differ in abundance and are transcribed from human-specific promoters. In summary, STK39 undergoes species-specific transcriptional regulation, resulting in differentially expressed alternative transcripts that have implications for the design and testing of novel SPAK-targeting antihypertensive medications. Copyright 2020 The Authors.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85080968175&doi=10.14814%2fphy2.14379&partnerID=40&md5=06976fed33953850e80e6b8eb22cbfae; http://hdl.handle.net/10713/12237
- Regulation of NKCC2 activity by inhibitory SPAK isoforms: KS-SPAK is a more potent inhibitor than SPAK2.
- Authors: Park HJ, Curry JN, McCormick JA
- Issue date: 2013 Dec 15
- Constitutively Active SPAK Causes Hyperkalemia by Activating NCC and Remodeling Distal Tubules.
- Authors: Grimm PR, Coleman R, Delpire E, Welling PA
- Issue date: 2017 Sep
- STE20/SPS1-related proline/alanine-rich kinase (SPAK) is critical for sodium reabsorption in isolated, perfused thick ascending limb.
- Authors: Cheng CJ, Yoon J, Baum M, Huang CL
- Issue date: 2015 Mar 1
- SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction.
- Authors: Yang SS, Lo YF, Wu CC, Lin SW, Yeh CJ, Chu P, Sytwu HK, Uchida S, Sasaki S, Lin SH
- Issue date: 2010 Nov
- Critical role of the SPAK protein kinase CCT domain in controlling blood pressure.
- Authors: Zhang J, Siew K, Macartney T, O'Shaughnessy KM, Alessi DR
- Issue date: 2015 Aug 15